Nothing Special   »   [go: up one dir, main page]

DK0584452T3 - Nye amyloid forstadieproteiner samt fremgangsmåder til anvendelse af samme - Google Patents

Nye amyloid forstadieproteiner samt fremgangsmåder til anvendelse af samme

Info

Publication number
DK0584452T3
DK0584452T3 DK93105718T DK93105718T DK0584452T3 DK 0584452 T3 DK0584452 T3 DK 0584452T3 DK 93105718 T DK93105718 T DK 93105718T DK 93105718 T DK93105718 T DK 93105718T DK 0584452 T3 DK0584452 T3 DK 0584452T3
Authority
DK
Denmark
Prior art keywords
methods
amyloid precursor
polypeptides
same
precursor proteins
Prior art date
Application number
DK93105718T
Other languages
English (en)
Inventor
Michael Peter Vitek
Jack Steven Jacobsen
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0584452T3 publication Critical patent/DK0584452T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/839—Nerves; brain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
DK93105718T 1992-05-01 1993-04-07 Nye amyloid forstadieproteiner samt fremgangsmåder til anvendelse af samme DK0584452T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87767592A 1992-05-01 1992-05-01

Publications (1)

Publication Number Publication Date
DK0584452T3 true DK0584452T3 (da) 2002-11-18

Family

ID=25370482

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93105718T DK0584452T3 (da) 1992-05-01 1993-04-07 Nye amyloid forstadieproteiner samt fremgangsmåder til anvendelse af samme

Country Status (14)

Country Link
US (4) US5656477A (da)
EP (1) EP0584452B1 (da)
JP (1) JP3937459B2 (da)
KR (1) KR100330830B1 (da)
AT (1) ATE221573T1 (da)
AU (1) AU667895B2 (da)
CA (1) CA2095421C (da)
DE (1) DE69332163T2 (da)
DK (1) DK0584452T3 (da)
ES (1) ES2182823T3 (da)
NZ (1) NZ247499A (da)
PT (1) PT584452E (da)
TW (1) TW327194B (da)
ZA (1) ZA933084B (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2123211C (en) * 1991-11-12 2008-09-16 Colin L. Masters A method for assaying and treating alzheimer's disease
US7196055B2 (en) 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
US6103689A (en) * 1994-08-31 2000-08-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US6867179B1 (en) 1994-08-31 2005-03-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US5863902A (en) * 1995-01-06 1999-01-26 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
US5948763A (en) * 1995-06-07 1999-09-07 New York University Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
WO1997021728A1 (en) * 1995-12-12 1997-06-19 Karolinska Innovations Ab PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
WO1997035998A1 (en) * 1996-03-28 1997-10-02 Trustees Of Boston University Methods of modulating melanin synthesis
ATE346303T1 (de) * 1996-03-29 2006-12-15 Univ Boston Mit alzheimer krankheit verknüpften verfahren zur diagnose, zur herstellung von medikamenten und zum screenen von substanzen sowie aus beta- amyloid abgeleiteten peptiden
DE19641180A1 (de) * 1996-09-24 1998-03-26 Schering Ag Verfahren zur Darstellung von APP-Sekretase Modulation und deren Verwendung als Mittel zur Behandlung der Alzheimer'schen Erkrankung
US6787319B2 (en) * 1997-04-16 2004-09-07 American Home Products Corp. β-amyloid peptide-binding proteins and polynucleotides encoding the same
US7005295B1 (en) 1997-04-16 2006-02-28 Wyeth β-amyloid peptide-binding proteins and polynucleotides encoding the same
US7799535B1 (en) 1997-12-09 2010-09-21 Arch Development Corporation Methods for identifying factors that control the folding of amyloid proteins of diverse origin
ATE420185T1 (de) * 1998-09-24 2009-01-15 Pharmacia & Upjohn Co Llc Alzheimersche krankheit sekretase
DE19856261C1 (de) * 1998-12-07 2000-03-30 Hoechst Marion Roussel De Gmbh Aß-Peptid Screening Assay
US6518011B1 (en) * 1999-01-13 2003-02-11 Bristol-Myers Squibb Company Method for screening compounds to identify beta-amyloid production modulators
US6593512B1 (en) 1999-03-03 2003-07-15 Cognosci, Inc. Transgenic mouse expressing human tau gene
US7060670B1 (en) 1999-05-05 2006-06-13 Neurochem (International) Limited Stereoselective antifibrillogenic peptides and peptidomimetics thereof
FR2796952B1 (fr) 1999-07-30 2003-08-15 Centre Nat Rech Scient Nouvelles applications de peptides issus du domaine cytoplasmique du precurseur de la proteine amyloide
CA2395926A1 (en) * 1999-12-28 2001-07-05 Curagen Corporation Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
CN1315353A (zh) * 2000-03-24 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人淀粉样糖蛋白9和编码这种多肽的多核苷酸
US6713276B2 (en) * 2000-06-28 2004-03-30 Scios, Inc. Modulation of Aβ levels by β-secretase BACE2
EP1793001B1 (en) * 2001-02-15 2011-11-09 The University of Chicago Yeast screens for agents affecting protein folding
ATE532874T1 (de) * 2001-02-15 2011-11-15 Univ Chicago Verfahren zum nachweis in hefe für mittels die proteinfaltung beeinflussen
US6815175B2 (en) * 2001-03-16 2004-11-09 Cornell Research Foundation, Inc. Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder
ATE544780T1 (de) * 2002-04-09 2012-02-15 Scripps Research Inst Hybrid-polypeptide mit eingefügten sequenzmotiven und ihre verwendungen
WO2004013172A2 (en) * 2002-07-24 2004-02-12 Innogenetics N.V. Fragments of beta-amyloid as targets for vaccination against alzheimer disease
AU2003279216A1 (en) * 2002-10-09 2004-05-04 Rinat Neuroscience Corp. Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
JP2007521792A (ja) * 2003-04-16 2007-08-09 ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ 異常に切断されたタンパク質を異所性発現する酵母、およびこの用途
US20050009110A1 (en) * 2003-07-08 2005-01-13 Xiao-Jia Chang Methods of producing antibodies for diagnostics and therapeutics
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
US20050112696A1 (en) * 2003-11-25 2005-05-26 The University Of Texas Southwestern Medical Center Compositions, methods and assays related to secretase cleavage specificity
EP1781704A2 (en) 2004-07-30 2007-05-09 Rinat Neuroscience Corp. Antibodies directed against amyloid-beta peptide and methods using same
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
PE20061323A1 (es) 2005-04-29 2007-02-09 Rinat Neuroscience Corp Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
US7704946B2 (en) * 2006-05-05 2010-04-27 Caritas St. Elizabeth's Medical Center Reversible inhibition of pyramidal gap junction activity
JP2011520108A (ja) * 2008-04-30 2011-07-14 ノバルティス アーゲー 病原性配座異性体についてのアッセイ
KR101825041B1 (ko) * 2016-04-07 2018-02-02 주식회사 바이오솔루션 물질 p를 포함하는 상처치유용 약학 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223482A (en) * 1986-11-17 1993-06-29 Scios Nova Inc. Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
EP0332640A1 (en) * 1986-11-17 1989-09-20 California Biotechnology, Inc. Recombinant alzheimer's amyloid protein
US4864859A (en) * 1988-07-25 1989-09-12 Allied-Signal Inc. Method for dynamically balancing a mechanism having a high speed rotating component
AU4216689A (en) * 1988-08-11 1990-03-05 California Biotechnology, Inc. Method for stabilizing heterologous protein expression and vectors for use therein
EP0447836A3 (en) * 1990-03-12 1991-10-02 American Cyanamid Company Amyloid peptide precursor rna
EP0451700A1 (en) * 1990-04-10 1991-10-16 Miles Inc. Recombinant APP minigenes for expression in transgenic mice as models for Alzheimers's disease
US5242932A (en) * 1991-12-17 1993-09-07 The Rockefeller University Treatment of amyloidosis associated with alzheimer disease
CA2086165A1 (en) * 1992-04-09 1993-10-10 Paul P. Tamburini Diagnostic assay for alzheimer's disease based on the proteolysis of alzheimer's precursor protein

Also Published As

Publication number Publication date
KR930023460A (ko) 1993-12-18
US5656477A (en) 1997-08-12
JP3937459B2 (ja) 2007-06-27
AU667895B2 (en) 1996-04-18
NZ247499A (en) 1996-04-26
US5693478A (en) 1997-12-02
US5652092A (en) 1997-07-29
EP0584452A1 (en) 1994-03-02
EP0584452B1 (en) 2002-07-31
ES2182823T3 (es) 2003-03-16
CA2095421C (en) 2008-11-18
KR100330830B1 (ko) 2002-11-23
DE69332163D1 (de) 2002-09-05
PT584452E (pt) 2002-12-31
ATE221573T1 (de) 2002-08-15
US5703209A (en) 1997-12-30
CA2095421A1 (en) 1993-11-02
DE69332163T2 (de) 2003-02-27
TW327194B (en) 1998-02-21
AU3835893A (en) 1993-11-04
JPH07132094A (ja) 1995-05-23
ZA933084B (en) 1993-11-24

Similar Documents

Publication Publication Date Title
DK0584452T3 (da) Nye amyloid forstadieproteiner samt fremgangsmåder til anvendelse af samme
EP0722461A4 (en) EXPRESSION OF FUSION POLYPEPTIDES TRANSPORTED OUT OF CYTOPLASM WITHOUT HEAD SEQUENCE
ES2076521T3 (es) Procedimiento para la disociacion enzimatica de proteinas recombinantes mediando utilizacion de proteasa de iga.
DE3852074D1 (de) Verfahren zur reinigung von rekombinanten polypeptiden.
PT83065B (pt) Processo para a preparacao de proteinas de fusao
FI875427A0 (fi) Menetelmä valmistaa hevosen -interferonia
FI921838A0 (fi) Foerbaettring av utbyte vid sekretion av proteiner med disulfidbryggor.
NO175003C (no) Fusjonsproteiner med eukaryotisk ballastandel, vektor som inneholder et DNA som koder for fusjonsproteinet samt E.coli celle inneholdene vektoren
KR880700855A (ko) 진핵생물 단백질을 발현시키는 개선된 방법
ATE325815T1 (de) Menschliches neurotrimin-homolog
DK1205546T3 (da) Polypeptider og nucleinsyrer kodende derfor
DE69032323D1 (de) Produktion und verwendung von antihelmintischen substanzen und schützenden immunogenen
PT81253B (pt) Processo para a preparacao de uma sequencia de sinal sintetica para o transporte de proteinas em sistemas de expressao
ES2111537T3 (es) Inhibidor de la ribonucleasa de placenta humana recombinante y metodo de produccion.
DE3789552D1 (de) Licht-induzierbarer promotor.
PT1207168E (pt) Polipeptidos e acidos nucleicos que os codificam
PT1205550E (pt) Polipeptidos e acidos nucleicos que os codificam
PT1217006E (pt) Polipeptidos e acidos nucleicos que os codificam
FI861559A0 (fi) Menetelmä hepatitis B-viruksen pinta-antigeenin PreS1-PreS2-S-proteiinin koodaavan alueen koodaamia proteiineja käsittävän proteiinin valmistamiseksi sekä menetelmässä käytettävät yhdistelmä-DNA-vektorit ja -kontameerit sekä nisäkässolut
PT1251173E (pt) Polipeptidos transmembranares e excretados e acidos nucleicos que os codificam
ES2090019T3 (es) Preparacion por tecnologia genetica de proteina pp15.
DK1241252T3 (da) Nucleinsyrer, der opformeres i tumorer samt relaterede materialer og fremgangsmåder
ATE319821T1 (de) Verfahren und produkt zur regulation der reaktionsempfindlichkeit von zellen auf externe signale
DK1241183T3 (da) Humant HCAR-agtig protein og nucleinsyrer kodende derfor